Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Feb;37(2):240–245. doi: 10.1128/aac.37.2.240

Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium.

S S Naidu 1, U Svensson 1, A R Kishore 1, A S Naidu 1
PMCID: PMC187646  PMID: 8383941

Abstract

The effect of lactoferrin (Lf) on bacterial growth was tested by measuring conductance changes in the cultivation media by using a Malthus-AT system and was compared with the magnitude of 125I-labeled Lf binding in 15 clinical isolates of Escherichia coli. The binding property was inversely related to the change in bacterial metabolic rate (r = 0.91) and was directly related to the degree of bacteriostasis (r = 0.79). The magnitude of Lf-bacterium interaction showed no correlation with the MIC of Lf. In certain strains, Lf at supraoptimal levels reduced the bacteriostatic effect. Thus, the Lf concentration in the growth media was critical for the antibacterial effect. The cell envelopes of Salmonella typhimurium 395MS with smooth lipopolysaccharide (LPS) and its five isogenic rough mutants revealed 38-kDa porin proteins as peroxidase-labeled-Lf-reactive components in sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot (ligand blot) analysis. However, in the whole cell binding assay, parent strain 395MS demonstrated a very low interaction with 125I-Lf. On the other hand, Lf interaction gradually increased in correspondence with the decrease in LPS polysaccharide moiety in the isogenic rough mutants. Conductance measurement studies revealed that the low-level-Lf-binding (low-Lf-binding) strain 395MS with smooth LPS was relatively insusceptible to Lf, while the high-Lf-binding mutant Rd was more susceptible to Lf. These data suggested a correlation between Lf binding to porins and the Lf-mediated antimicrobial effect. The polysaccharide moiety of LPS shielded porins from the Lf interaction and concomitantly decreased the antibacterial effect.

Full text

PDF
240

Images in this article

243Image
on p.243

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambruso D. R., Johnston R. B., Jr Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system. J Clin Invest. 1981 Feb;67(2):352–360. doi: 10.1172/JCI110042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnold R. R., Brewer M., Gauthier J. J. Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect Immun. 1980 Jun;28(3):893–898. doi: 10.1128/iai.28.3.893-898.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arnold R. R., Cole M. F., McGhee J. R. A bactericidal effect for human lactoferrin. Science. 1977 Jul 15;197(4300):263–265. doi: 10.1126/science.327545. [DOI] [PubMed] [Google Scholar]
  4. Arnold R. R., Russell J. E., Champion W. J., Brewer M., Gauthier J. J. Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation. Infect Immun. 1982 Mar;35(3):792–799. doi: 10.1128/iai.35.3.792-799.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Arnold R. R., Russell J. E., Champion W. J., Gauthier J. J. Bactericidal activity of human lactoferrin: influence of physical conditions and metabolic state of the target microorganism. Infect Immun. 1981 May;32(2):655–660. doi: 10.1128/iai.32.2.655-660.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bennett R. M., Davis J. Lactoferrin binding to human peripheral blood cells: an interaction with a B-enriched population of lymphocytes and a subpopulation of adherent mononuclear cells. J Immunol. 1981 Sep;127(3):1211–1216. [PubMed] [Google Scholar]
  7. Benz R. Structure and function of porins from gram-negative bacteria. Annu Rev Microbiol. 1988;42:359–393. doi: 10.1146/annurev.mi.42.100188.002043. [DOI] [PubMed] [Google Scholar]
  8. Brock J. H. Lactoferrin in human milk: its role in iron absorption and protection against enteric infection in the newborn infant. Arch Dis Child. 1980 Jun;55(6):417–421. doi: 10.1136/adc.55.6.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bullen C. L., Willis A. T. Resistance of the breast-fed infant to gastroenteritis. Br Med J. 1971 Aug 7;3(5770):338–343. doi: 10.1136/bmj.3.5770.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bullen J. J., Armstrong J. A. The role of lactoferrin in the bactericidal function of polymorphonuclear leucocytes. Immunology. 1979 Apr;36(4):781–791. [PMC free article] [PubMed] [Google Scholar]
  11. Bullen J. J., Rogers H. J., Leigh L. Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Br Med J. 1972 Jan 8;1(5792):69–75. doi: 10.1136/bmj.1.5792.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dalmastri C., Valenti P., Visca P., Vittorioso P., Orsi N. Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface. Microbiologica. 1988 Jul;11(3):225–230. [PubMed] [Google Scholar]
  13. Ellison R. T., 3rd, Giehl T. J., LaForce F. M. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun. 1988 Nov;56(11):2774–2781. doi: 10.1128/iai.56.11.2774-2781.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gadó I., Erdei J., Laszlo V. G., Pászti J., Czirók E., Kontrohr T., Tóth I., Forsgren A., Naidu A. S. Correlation between human lactoferrin binding and colicin susceptibility in Escherichia coli. Antimicrob Agents Chemother. 1991 Dec;35(12):2538–2543. doi: 10.1128/aac.35.12.2538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Griffiths E., Humphreys J. Bacteriostatic effect of human milk and bovine colostrum on Escherichia coli: importance of bicarbonate. Infect Immun. 1977 Feb;15(2):396–401. doi: 10.1128/iai.15.2.396-401.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kalmar J. R., Arnold R. R. Killing of Actinobacillus actinomycetemcomitans by human lactoferrin. Infect Immun. 1988 Oct;56(10):2552–2557. doi: 10.1128/iai.56.10.2552-2557.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kishore A. R., Erdei J., Kalfas S., Forsgren A., Naidu A. S. Detection of bacterial interaction with lactoferrin by an enzyme-linked ligand binding assay (ELBA). J Med Microbiol. 1992 Nov;37(5):341–345. doi: 10.1099/00222615-37-5-341. [DOI] [PubMed] [Google Scholar]
  18. Kishore A. R., Erdei J., Naidu S. S., Falsen E., Forsgren A., Naidu A. S. Specific binding of lactoferrin to Aeromonas hydrophila. FEMS Microbiol Lett. 1991 Sep 15;67(1):115–119. doi: 10.1016/0378-1097(91)90454-i. [DOI] [PubMed] [Google Scholar]
  19. Lima M. F., Kierszenbaum F. Lactoferrin effects on phagocytic cell function. I. Increased uptake and killing of an intracellular parasite by murine macrophages and human monocytes. J Immunol. 1985 Jun;134(6):4176–4183. [PubMed] [Google Scholar]
  20. Lugtenberg B., Van Alphen L. Molecular architecture and functioning of the outer membrane of Escherichia coli and other gram-negative bacteria. Biochim Biophys Acta. 1983 Mar 21;737(1):51–115. doi: 10.1016/0304-4157(83)90014-x. [DOI] [PubMed] [Google Scholar]
  21. Maneva A. I., Sirakov L. M., Manev V. V. Lactoferrin binding to neutrophilic polymorphonuclear leucocytes. Int J Biochem. 1983;15(7):981–984. doi: 10.1016/0020-711x(83)90179-9. [DOI] [PubMed] [Google Scholar]
  22. Markwell M. A. A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum. Anal Biochem. 1982 Sep 15;125(2):427–432. doi: 10.1016/0003-2697(82)90025-2. [DOI] [PubMed] [Google Scholar]
  23. Marr A. G., Ingraham J. L. EFFECT OF TEMPERATURE ON THE COMPOSITION OF FATTY ACIDS IN ESCHERICHIA COLI. J Bacteriol. 1962 Dec;84(6):1260–1267. doi: 10.1128/jb.84.6.1260-1267.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Masson P. L., Heremans J. F. Metal-combining properties of human lactoferrin (red milk protein). 1. The involvement of bicarbonate in the reaction. Eur J Biochem. 1968 Dec 5;6(4):579–584. doi: 10.1111/j.1432-1033.1968.tb00484.x. [DOI] [PubMed] [Google Scholar]
  25. Masson P. L., Heremans J. F., Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med. 1969 Sep 1;130(3):643–658. doi: 10.1084/jem.130.3.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Naidu A. S., Andersson M., Forsgren A. Identification of a human lactoferrin-binding protein in Staphylococcus aureus. J Med Microbiol. 1992 Mar;36(3):177–183. doi: 10.1099/00222615-36-3-177. [DOI] [PubMed] [Google Scholar]
  27. Naidu A. S., Miedzobrodzki J., Andersson M., Nilsson L. E., Forsgren A., Watts J. L. Bovine lactoferrin binding to six species of coagulase-negative staphylococci isolated from bovine intramammary infections. J Clin Microbiol. 1990 Oct;28(10):2312–2319. doi: 10.1128/jcm.28.10.2312-2319.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Naidu A. S., Miedzobrodzki J., Musser J. M., Rosdahl V. T., Hedström S. A., Forsgren A. Human lactoferrin binding in clinical isolates of Staphylococcus aureus. J Med Microbiol. 1991 Jun;34(6):323–328. doi: 10.1099/00222615-34-6-323. [DOI] [PubMed] [Google Scholar]
  29. Naidu S. S., Erdei J., Czirók E., Kalfas S., Gadó I., Thorén A., Forsgren A., Naidu A. S. Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections. APMIS. 1991 Dec;99(12):1142–1150. [PubMed] [Google Scholar]
  30. Nikaido H., Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol Rev. 1985 Mar;49(1):1–32. doi: 10.1128/mr.49.1.1-32.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Oram J. D., Reiter B. Inhibition of bacteria by lactoferrin and other iron-chelating agents. Biochim Biophys Acta. 1968 Dec 23;170(2):351–365. doi: 10.1016/0304-4165(68)90015-9. [DOI] [PubMed] [Google Scholar]
  32. Peterson K. M., Alderete J. F. Iron uptake and increased intracellular enzyme activity follow host lactoferrin binding by Trichomonas vaginalis receptors. J Exp Med. 1984 Aug 1;160(2):398–410. doi: 10.1084/jem.160.2.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rainard P. Bacteriostasis of Escherichia coli by bovine lactoferrin, transferrin and immunoglobulins (IgG1, IgG2, IgM) acting alone or in combination. Vet Microbiol. 1986 Feb;11(1-2):103–115. doi: 10.1016/0378-1135(86)90011-8. [DOI] [PubMed] [Google Scholar]
  34. Rana F. R., Macias E. A., Sultany C. M., Modzrakowski M. C., Blazyk J. Interactions between magainin 2 and Salmonella typhimurium outer membranes: effect of lipopolysaccharide structure. Biochemistry. 1991 Jun 18;30(24):5858–5866. doi: 10.1021/bi00238a008. [DOI] [PubMed] [Google Scholar]
  35. Reite B., Oram J. D. Bacterial inhibitors in milk and other biological fluids. Nature. 1967 Oct 28;216(5113):328–330. doi: 10.1038/216328a0. [DOI] [PubMed] [Google Scholar]
  36. Reiter B., Brock J. H., Steel E. D. Inhibition of Escherichia coli by bovine colostrum and post-colostral milk. II. The bacteriostatic effect of lactoferrin on a serum susceptible and serum resistant strain of E. coli. Immunology. 1975 Jan;28(1):83–95. [PMC free article] [PubMed] [Google Scholar]
  37. Saito H., Miyakawa H., Tamura Y., Shimamura S., Tomita M. Potent bactericidal activity of bovine lactoferrin hydrolysate produced by heat treatment at acidic pH. J Dairy Sci. 1991 Nov;74(11):3724–3730. doi: 10.3168/jds.S0022-0302(91)78563-9. [DOI] [PubMed] [Google Scholar]
  38. Spik G., Cheron A., Montreuil J., Dolby J. M. Bacteriostasis of a milk-sensitive strain of Escherichia coli by immunoglobulins and iron-binding proteins in association. Immunology. 1978 Oct;35(4):663–671. [PMC free article] [PubMed] [Google Scholar]
  39. Stephens S., Dolby J. M., Montreuil J., Spik G. Differences in inhibition of the growth of commensal and enteropathogenic strains of Escherichia coli by lactotransferrin and secretory immunoglobulin A isolated from human milk. Immunology. 1980 Nov;41(3):597–603. [PMC free article] [PubMed] [Google Scholar]
  40. Stuart J., Norrell S., Harrington J. P. Kinetic effect of human lactoferrin on the growth of Escherichia coli 0111. Int J Biochem. 1984;16(10):1043–1047. doi: 10.1016/0020-711x(84)90085-5. [DOI] [PubMed] [Google Scholar]
  41. Tigyi Z., Kishore A. R., Maeland J. A., Forsgren A., Naidu A. S. Lactoferrin-binding proteins in Shigella flexneri. Infect Immun. 1992 Jul;60(7):2619–2626. doi: 10.1128/iai.60.7.2619-2626.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Van Snick J. L., Masson P. L. The binding of human lactoferrin to mouse peritoneal cells. J Exp Med. 1976 Dec 1;144(6):1568–1580. doi: 10.1084/jem.144.6.1568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Yu F., Mizushima S. Roles of lipopolysaccharide and outer membrane protein OmpC of Escherichia coli K-12 in the receptor function for bacteriophage T4. J Bacteriol. 1982 Aug;151(2):718–722. doi: 10.1128/jb.151.2.718-722.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. van der Ley P., de Graaff P., Tommassen J. Shielding of Escherichia coli outer membrane proteins as receptors for bacteriophages and colicins by O-antigenic chains of lipopolysaccharide. J Bacteriol. 1986 Oct;168(1):449–451. doi: 10.1128/jb.168.1.449-451.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES